Innovative Medical Technology

Neurotron, Incorporated

   Innovative Medical Technology

                 Established 1981

Neurometer® Endocrinology, Diabetes, Pre-Diabetes, Obesity, Metabolic Syndrome Neuropathy Publications

 Patient Care


 Press Releases






 Clinical Apps







  1. Lee, W-C, Wu, H-P, Tai,T-Y, Yu, H-J, Chiang, P-H.. Investigation of Urodynamic Characteristics and Bladder Sensory Function in the Early Stages of Diabetic Bladder Dysfunction in Women With Type 2 Diabetes. Journal of Urology , Vol. 181,(1) 198-203, 2009.

  2.  Putz, Z., Tabák, A., Tóth, N., Istenes, I., Németh, N., Gandhi, R., Hermányi, Z., Keresztes, K., Jermendy, G., Tesfaye, S., & Kempler, P. Noninvasive Evaluation of Neural Impairment in Subjects With Impaired Glucose Tolerance. Diabetes Care, Vol.32(1), 181-3, 2009. 

  3. Varkonyi, T. T.; Szabolcs, A.; Szidor, V.; Szasz, A.; Borcsok, E.; Lengyel, C.; Takacs, T.; Kempler, P.; Wittmann, T.   Evaluation of exocrine pancreatic function in patients with type 1 and type 2 diabetes. Presented at the 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Diabetologia,  Vol.52. Suppl.1, Poster, 1026, Sep.2009.

  4. Oh,O.S.H., Sung, J.J., Hong, Y.H., Park, S. H., Lee, K.W., Park, W.S.. The value of measuring current perception threshold in diabetic sensory polyneuropathy with normal routine NCS. European Journal of Anaesthesiology Vol. 25(Suppl. 43): 1–36, 2008.

  5. Putz, Z.,Tabák, A., Tóth, N., Istenes, I., Németh, N., Gandhi, R., Hermányi, Z., Keresztes, K., Jermendy, G., Tesfaye, S., Kempler, P. Small fiber neuropathy and impaired autonomic function neuropathy in subjects with impaired glucose tolerance. Diabetologia, Vol.51 (Suppl.1), S501, 2008.

  6. Kurashvili, G., Kurashvili, R., Kurashvili, M.,Tsutskiridze, L., Shelestova, E., Kobaidze, M. Cardiac autonomic and peripheral neuropathy in newly diagnosed type 2 diabetic patients. Endocrine Abstracts,Vol 16:231, 2008.

  7. Shibata T, Naruse K, Kamiya H, Kozakae M, Kondo M, Yasuda Y, Nakamura N, Ota K, Tosaki T, Matsuki T, Nakashima E, Hamada Y, Oiso Y, Nakamura J. Transplantation of Bone Marrow-derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats. Diabetes, Vol 57. 3099-3107, 2008.

  8. Inukai, T.,  Matsutomo, R., Hara, K., Nakano, T.,  Suetsugu, M., Matsumoto, S.,  Nakamachi, T.,  Takebayashi, K.,  Aso, Y. Current perception threshold determined with a novel method, the Neurometer is clinically useful in detecting functional abnormalities of large and medium-size myelinated nerve fibres in patients with type 2 diabetes mellitus. Diabetologia ,Vol. 51( Suppl 1), 2008
  9. Chiheb, S., Pinal, I., Rivero L.M., Cosson, E., Nguyen, M.T., Katims, J.J, Valensi, P. Neuroselective electrodiagnostic evaluation of peripheral sensory nerve function in obese patients without diabetes. NEURODIAB XVIII,  18th Annual Meeting of the Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes. Poster 51 Orvieto, Italy, 2008.
  10. Kurashvili, G., Kurashvili, R., Tsutskiridze, L., Shelestova, E. Efficacy of a-Lipoic acid in Newly Diagnosed Type 2 Diabetes. Diabetic Medicine, Vol. 23 (Suppl. 4):P221, 2006.
  11. Hermányi, Z., Putz, Z., Tóth, N., Berta, B., Keresztes, K., Istenes, I., Kempler, P. The Separate and Combined Effects of Benfotiamin and Alpha-Lipoic Acid on the Progression of Diabetic Neuropathy. Diabetalogia, 2006.
  12. Keresztes, K., Istenes, I., Vargha, P., Kempler, P. Higher Fasting Glucose Levels Within the Normal Range are Associated with Sensory Nerve Dysfunction in Patients with Essential Hypertension. Diabetologia, Vol. 49 (l. 1):1034, 2006.
  13. Kiss, J-G, Tóth, F, Várkonyi, T-T, Rovó, L, Lengyel, C, Légrádi, P, Jóri, J Brainstem auditory evoked potential (BAEP) examinations in diabetic patients. 77th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery, Mannheim, Düsseldorf, Köln: German Medical Science; 2006.
  14. Kempler, P., Keresztes, K., Istenes, I., Hermányi, Z., Vargha, P. Complete Restoration of Sensory Nerve Dysfunction I Newly diagnosed Type 1 Diabetic Patients Following Long Term Benfotiamine Treatment (Two Cases). 7th International Symposium on Diabetic Neuropathy, Somerset West, South Africa. Vol. 49, P. 2, 2006.
  15. Barlao, L., Váradi, G., Kempler, P., Mazsaroff, C., Vámosi, I. Beta-Fibrinogen Gene G/A-455 Polymorphism in Relation to Subclinical Diabetes Complications in Children and Adolescents with Type 1 Diabetes. Diabetes,  Vol. 54(1881-P;Suppl. 1):A452, 2005.
  16. Yang, G., Yuan, S., Du, Y., et al. Clinical Analysis of Diabetic Sensory Neuropathy with Neurometer. Chinese Journal of Coal Industry Medicine, Vol. 8(1): 62- 63, 2005.
  17. Matsutomo, R., Suetsugu, M., Yamamoto, R., Matsumoto, S., Wakabayashi, S., Takebayashi, K., Aso, Y., Takemura, Y., Inukai, T. Measurement of Current Perception Threshold Determined by Neurometer® Accurately Reflects the Progression of Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus. 64th Scientific Session, American Diabetes Association, poster presentation, 2004.
  18. Prendergast, J.J., Miranda, G., Sanches, M. Improvement of sensory impairment in patients with peripheral neuropathy. Endocrine Practice, Vol. 10(1):21-30, 2004.
  19. Yang, G., Yuan, S., Li, H., et al. Clinical investigation of sensory nerve function in 100 diabetic patients. Basic Medical Sciences and Clinics, Vol. 24(3): 352-353, 2004.
  20. Yang G., Li H., Yuan S., et al. Sensory nerve function in diabetic patients and the relationship with lower extremity arterial disease. Chinese J. of Diabetes, Vol. 13(1):11-13, 2003.
  21. Weintraub, M.I., Wolfe, G.I., Barohn, R.A., Cole, S.P., Parry, G.J., Hayat, G., Cohen, J.A., Page, J.C., Bromberg, M.B.,, Schwartz, S.L., and Magnetic Research Group. Static Magnetic Field Therapy for Symptomatic Diabetic Neuropathy: A randomized, Double-Blind, Placebo-Controlled Trail. Arch Phys Med Rehabil,  Vol. 84:736-46, 2003.
  22. Keresztes, K., Istenes, I., Hermányi, Z., Vargha, P., Barna, I, Kempler, P. Risk Factors of Autonomic and Sensory Nerve Dysfunction in Patients With Newly Diagnosed Type 1 Diabetes. Diabetes Care, Vol. 26:2213-2214, 2003.
  23. Du, Y., Yang G., Yuan S., et al. Experience of Neurometer Assessing Sensory Nerve Function in Diabetic Patients. Chinese Academy of Clinical Medicine,Vol. 3(23): 14-16, 2002.
  24. Várkonyi, T.T., Petõõ, T., Déégi, R., Keresztes, K., Lengyel, C., Janááky, M.,Kempler, P., Lonovics, J. Impairment of Visual Evoked Potentials: An early central manifestation of diabetic neuropathy? Diabetes Care, Vol. 25:1661-1662, 2002.
  25. Oishi, M., Mochizuki, Y., Suzuki, Y., Ogawa, K., Naganuma, T., Nishijo, Y., Mizutani, T. Current perception threshold and sympathetic skin response in diabetic and alcoholic polyneuropathies. Internal Medicine, Vol. 41(10):819-822, 2002.
  26. Domeisen, U., Schwegler, B., Spinas, G.A., Lehmann, R. The Prevalence of Peripheral and Autonomic Neuropathy in Patients With Type 2 Diabetes Mellitus in a Diabetes Clinic. American Diabetes Association Annual Meeting, Abstract 2139, 2002.
  27. Takekuma, K.; Ando, F.; Niino, N.; Shimokata, H. Prevalence of hyperesthesia detected by current perception threshold test in subjects with glucose metabolic impairments in a community. Internal Medicine,  Vol. 41(12):1124-9, 2002.
  28. Várkoni, T.T., Tóth, F., Róvo, L., Lengyel, with., Kiss, J.G., Kempler, P., Lonovics, J. Impairment of the auditory brainstem function in diabetic neuropathy. Diabetes Care, Vol. 25(3):631-632, 2002.
  29. Várkonyi, T.T., Lengyel, C., Madácsy, L., Velösy, B., Kempler, P., Fazekas, T., Pávics, L., Csernay, L., Lonovics, J. Gallbladder Hypomotility in diabetic neuropathy. Clinical Autonomic Research, Vol. 11:377-381, 2001.
  30. Jiang, Y-D, Hsich, S-T, Wu, H-P, Tai, T-Y, Katims, J.J., Chuang, L-M. Characterization of hyperesthetic stage of diabetic neuropathy with current perception threshold, a method for diabetic neuropathy staging. Diabetic Neuropathy Study Group of the European Association for the Study Diabetes, (EASD) NEURODIAB XI Meeting,  2001.
  31. Rice, B. Mind-Body Interventions. (From Research to Practice/Complementary & Integrative Medicine). Diabetes Spectrum, September 22, 2001.
  32. Barkai, L., Kempler, P. Puberty as a risk factor of Diabetic Neurpathy. Diabetes Care, Vol. 23(7):1044-1045, 2000.
  33. Cozzarelli J. How sensory Nerve Conduction Threshold Evaluations Can Facilitate Early Detections and Improved Outcomes. Podiatry Today ,:58-61, 2000.
  34. Farkas, G., R., Degi, Varkoni, T., Vörös P., Lengyel, Cs, Fetal Islet Grafting Prevents Secondary Diabetic Complications, Diabetologia, Vol. 43 (Suppl 1):A28, 2000.
  35. Cheng, W.-Y., Jiang, Y-D., Chuang, L.-M., Huang, C.-N, Heng, L.-T., Wu, H.-P., Tai, T.-Y., Lin, B.J. Quantitative sensory testing and risk factors of diabetic sensory neuropathy. Journal of Neurology, Vol. 246: 394-398, 1999.
  36. Varkonyi T, Roka, R., Legrady, P., Lazar, M., Lengyel, Cs, Madacsy, L., Velosy, B., Kempler, P., Pavics, L., Lonovics, J., Characterization of gastrointestinal motor dysfunction in patients with long- standing diabetes mellitus, Z Gastroenterol, Vol. 37:455, 1999.
  37. Winkler, G., Pal, B., Nagybeganyi, E., Ory, I., Porochnavec, M., Kempler, P. Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. Arzneim.-Forsch./Drug Reseach, Vol. 49:220-224, 1999.
  38. Lengyel, C., Török, T., Várkonyi, T., Kempler, P., Rudas, L. Baroreflex Sensitivity and Heart-Rate Variability in Insulin-Dependent Diabetics with Polyneuropathy. The Lancet ,Vol. 351(1823):1436-1437, 1998.
  39. Barkai, L., Kempler, P., Vámosi, I., Lukács, K., Marton, A., Keresztes, K. Peripheral Sensory Nerve Dysfunction in Children and Adolescents with Type 1 Diabetes Mellitus. Diabetic Medicine, Vol. 15:228-233, 1998.
  40. Várkonyi, T.T., Farkas, G., Fülöp, Z., Vörös, P., Lengyel, Cs., Kempler, P., Lonovics, J. Beneficial Effect of Fetal Islet Grafting on Development of Late Diabetic Complications. Transplantation Proceedings, Vol. 30:330-331, 1998.
  41. Umezawa, S., Kanamori, A., Yajima, Y., Aoki, C. Current Perception Threshold in evaluating diabetic neuropathy. Diabetes Vol. 8(1):711-719, 1997.
  42.  Fielding, R. Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. (insulin-dependent diabetes mellitus). Diabetes, Vol. 46:1846-1852, 1997.
  43. Lee, Y., Robinson, M., Wong, N., Chan, E., Charles, M. A. The effect of pentoxifylline on current perception thresholds in patients with diabetic sensory neuropathy. Journal of Diabetes Complications, Vol. 11(5):274-278, 1997.
  44. Kempler, P., Keresztes, K., Marton, A., Hermányi, Zs., Vargha, P., Gyula, T. Comprehensive evaluation of peripheral sensory nerve dysfunction by Neurometer® CPT evaluation in non-insulin dependent diabetes mellitus and in newly diagnosed non-insulin dependent diabetes mellitus. Magyar Belorvosi Archivum (Hungary). Vol. 3:163-167, 1995.
  45. Suzuki, K.I., Chung, Y., Yuka, Kobayashi, Goto, Y. Current Perception Thresholds: A New Method for the Assessment of Peripheral Sensory Neuropathy in Diabetes Mellitus. Peripheral Nerve 6(1):59-63, 1995.
  46. Pitei, D.L., Watkins, P.J., Stevens, M.J., Edmonds, M.E. The Value of the Neurometer® CPT in Assessing Diabetic Neuropathy by Measurement of the Current Perception Threshold. Diabetic Medicine, Vol. 11:872-876, 1994.
  47. Rendell, M., Bamisedun, O. Skin Blood Flow and Current Perception in Pentoxifylline-Treated Diabetic Neuropathy. Angiology, Vol. 43(10):843-851,1992.
  48. Veves, A., Malik, R., Townsend, C., Thompson, S., Boulton, A.J.M. Unmyelinated Fibre Pathology in Diabetic Patients with Mild Neuropathy. Diabetologia, Vol. 35, (supp1):16A, 1992.
  49. Rice, B.I., Schindler, J.V. Increased Sensory Nerve Function of the Peroneal Nerve in Response to Biofeedback Assisted Relaxation Training in a Population with Diabetes. Diabetes, Vol. 41, (Supp1):33A, 1992.
  50. Masson, E.A., Boulton, A.J.M. The Neurometer: Validation and Comparison with Conventional Tests for Diabetic Neuropathy. Diabetic Medicine, Vol. 8:S63-S66, 1991.
  51. Masson, E.A., Veves, A., Fernando, D., Boulton, A.J.M. Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia, Vol. 32:724-728, 1989.
  52. Rendell, M.S., Dovgan, D.J., Bergman, T.F., O'Donnell, G.P., Drobny, E.P., Katims, J.J. Mapping Diabetic Sensory Neuropathy by Current Perception Threshold Testing. Diabetes Care, Vol. 12(9):636-640, 1989.
  53. Rendell, M.S., Katims, J.J., Richter, R., Rowland, F. A comparison of nerve conduction velocities and current perception thresholds as correlates of clinical severity of diabetic sensory neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, Vol. 52:502-511, 1989.
  54. Guthrie, D.W., Kingery, D., Schulz, T., Childs, B., Guthrie, R.A., Parks, L. Screening for hype in children who have diabetes mellitus. International Study Group of Diabetes in Children, International Diabetes Federation, Australia, 1988.

top of page      Previous page     Home



The entire contents of this web site are Copyright 1996-2010, Neurotron, Incorporated

Est. 1981, Baltimore, MD, USA.  All rights reserved, worldwide

rev 04/16/10